Development of a clinical prediction model using digital device data for interstitial lung disease in patients with unresectable stage III non-small cell lung cancer treated with durvalumab
{{output}}
Background: Early detection of interstitial lung disease including radiation pneumonitis (ILD/RP) is crucial in consolidative durvalumab therapy after chemoradiotherapy (CRT) in unresectable stage III non-small cell lung cancer. ... ...
